Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
10/8/24 Stealth Biotherapeutics Elamipretide (Systemic Delivery) for Cardiomyopathy - Dilated Subscribers Only Subscribers Only Subscribers Only
10/8/24 Merck (MRK) Keytruda for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only
9/27/24 Johnson (JNJ) Darzalex Faspro for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
9/26/24 AbbVie (ABBV) Tavapadon for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
9/26/24 Enanta (ENTA) EDP-323 for Respiratory Syncytial Virus (RSV) Treatment Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
09/12/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/30/24 Subscribers Only Subscribers Only Trial Data - Top-Line Results
09/30/24 Subscribers Only Subscribers Only Trial Announcement - Other
09/30/24 Subscribers Only Subscribers Only Trial Announcement - Initiation (Emerging Markets)
09/30/24 Subscribers Only Subscribers Only Trial Announcement - Initiation